Analystreport

aTyr Pharma Inc (NASDAQ: LIFE) is now covered by analysts at Roth Capital. They set a "buy" rating and a $15.00 price target on the stock.

Ethos Technologies Inc. - Class A  (LIFE) 
Last ethos technologies inc. - class a earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media